Heterologous erythromycin production across strain and plasmid construction

Biotechnology Progress

Volumn 34, Issue 1, 2018, Pages 271-276

  Fang, Lei ^a   Guell, Marc ^b   Church, George M ^b   Pfeifer, Blaine A ^a  

^a the State University of New York   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

antibiotic; E. coli; erythromycin; heterologous; polyketide

Indexed keywords

BIOSYNTHESIS; CARBON; DNA; ESCHERICHIA COLI; KETONES; METABOLISM;

BIOSYNTHETIC PATHWAY; E. COLI; ERYTHROMYCIN; ERYTHROMYCIN PRODUCTION; GENOMIC ENGINEERINGS; HETEROLOGOUS; POLYKETIDES; TRANSFER CAPACITIES;

ANTIBIOTICS;

CARBON; ERYTHROMYCIN;

BIOSYNTHESIS; CHEMISTRY; ESCHERICHIA COLI; GENETICS; GENOMICS; METABOLIC ENGINEERING; METABOLISM; PLASMID; PROCEDURES;

BIOSYNTHETIC PATHWAYS; CARBON; ERYTHROMYCIN; ESCHERICHIA COLI; GENOMICS; METABOLIC ENGINEERING; PLASMIDS;

EID: 85031323768     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.2567     Document Type: Article

References (25)

1. Haight TH, Finland M. The antibacterial action of erythromycin. Proc Soc Exp Biol Med. 1952;81:175–183.
2. Kibwage IO, Hoogmartens J, Roets E, Vanderhaeghe H, Verbist L, Dubost M, Pascal C, Petitjean P, Levol G. Antibacterial activities of erythromycins A, B, C, and D and some of their derivatives. Antimicrob Agents Chemother. 1985;28:630–633.
3. Carreras C, Pieper R, Khosla C. The Chemistry and Biology of Fatty Acid, Polyketide, and Nonribosomal Peptide Biosynthesis, Vol. 188. Springer-Verlag: Heidelberg, 1997:86–126.
4. Zhang G, Li Y, Fang L, Pfeifer BA. Tailoring pathway modularity in the biosynthesis of erythromycin analogs heterologously engineered in E. coli. Sci Adv. 2015;1:e1500077.
5. Zhang H, Wang Y, Wu J, Skalina K, Pfeifer BA. Complete biosynthesis of erythromycin A and designed analogs using E. coli as a heterologous host. Chem Biol. 2010;17:1232–1240.
6. Cane DE. Programming of erythromycin biosynthesis by a modular polyketide synthase. J Biol Chem. 2010;285:27517–27523.
7. Minas W. Production of Erythromycin With Saccharopolyspora erythraea. Humana Press: Totowa, NJ; 2004:65–89.
8. Baneyx F. Recombinant protein expression in Escherichia coli. Curr Opin Biotechnol. 1999;10:411–421.
9. Zhang H, Boghigian BA, Armando J, Pfeifer BA. Methods and options for the heterologous production of complex natural products. Nat Prod Rep. 2011;28:125–151.
10. Peiru S, Menzella HG, Rodriguez E, Carney J, Gramajo H. Production of the potent antibacterial polyketide erythromycin C in Escherichia coli. Appl Environ Microbiol. 2005;71:2539–2547.
11. Lee HY, Khosla C. Bioassay-guided evolution of glycosylated macrolide antibiotics in Escherichia coli. PLoS Biol. 2007;5:e45.
12. Jiang M, Fang L, Pfeifer BA. Improved heterologous erythromycin a production through expression plasmid re-design. Biotechnol Prog. 2013;29:862–869.
13. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA. 2000;97:6640–6645.
14. Studier FW, Moffatt BA. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol. 1986;189:113–130.
15. Pfeifer BA, Admiraal SJ, Gramajo H, Cane DE, Khosla C. Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. Science. 2001;291:1790–1792.
16. Zhang H, Boghigian BA, Pfeifer BA. Investigating the role of native propionyl-CoA and methylmalonyl-CoA metabolism on heterologous polyketide production in Escherichia coli. Biotechnol Bioeng. 2010;105:567–573.
17. Zhang H, Fang L, Osburne MS, Pfeifer BA. The continuing development of E. coli as a heterologous host for complex natural product biosynthesis. Methods Mol Biol. 2016;1401:121–134.
18. Mierendorf RC, Morris BB, Hammer B, Novy RE. Expression and purification of recombinant proteins using the pET system. Methods Mol Med. 1998;13:257–292.
19. Cortes J, Haydock SF, Roberts GA, Bevitt DJ, Leadlay PF. An unusually large multifunctional polypeptide in the erythromycin-producing polyketide synthase of Saccharopolyspora erythraea. Nature. 1990;348:176–178.
20. Donadio S, Staver MJ, McAlpine JB, Swanson SJ, Katz L. Modular organization of genes required for complex polyketide biosynthesis. Science. 1991;252:675–679.
21. Reeves AR, English RS, Lampel JS, Post DA, Vanden Boom TJ. Transcriptional organization of the erythromycin biosynthetic gene cluster of Saccharopolyspora erythraea. J Bacteriol. 1999;181:7098–7106.
22. Summers RG, Donadio S, Staver MJ, Wendt-Pienkowski E, Hutchinson CR, Katz L. Sequencing and mutagenesis of genes from the erythromycin biosynthetic gene cluster of Saccharopolyspora erythraea that are involved in l-mycarose and d-desosamine production. Microbiology. 1997;143:3251–3262.
23. Hiraga S. Chromosome and plasmid partition in Escherichia coli. Annu Rev Biochem. 1992;61:283–306.
24. Jiang M, Pfeifer BA. Metabolic and pathway engineering to influence native and altered erythromycin production through E. coli. Metab Eng. 2013;19C:42–49.
25. Jiang M, Zhang H, Park SH, Li Y, Pfeifer BA. Deoxysugar pathway interchange for erythromycin analogues heterologously produced through Escherichia coli. Metab Eng. 2013;20:92–100.